芍黃通便合劑治療腸道氣滯型便秘的隨機對照臨床試驗
[Abstract]:Objective to observe the clinical efficacy and safety of Shaihuang Tongbian mixture in the treatment of intestinal qi stagnation constipation. Methods 144 patients with intestinal qi stagnation constipation were randomly divided into experimental group and control group, 72 cases in each group. The experimental group was treated with Shaohuangtongbian mixture (main ingredients: Radix Paeoniae Alba, Radix et Rhizoma Rhei, Huo Ma Ren, Cassia seed, etc.), each time 20 mL, 3 times a day, while the control group took Muxiang Areca Pill, 6 g each time, 3 times a day, the defecation stopped, followed up for 7 days. Observe stool meaning, defecation frequency, defecation shape (according to Bristol stool classification criteria), defecation time, defecation volume, accompanied by defecation (pain, abdominal distension, defecation difficulty, exhaust, etc.) and main related signs. Changes of physical and chemical indexes; Adverse drug reactions were observed in two groups. Results after treatment, the total effective rate was 91.94% (57 / 62 cases) in the experimental group and 90.16% (55 / 61 cases) in the control group (P0.05). After treatment, the scores of stool and defecation frequency were (4.81 鹵0.80), (, 4.65 鹵0.74), (4.19 鹵0.78), (, 4.26 鹵0.84), respectively. The scores of fecal quality, defecation time and defecation volume were (4.91 鹵0.76), (, 4.81 鹵0.88), (5.11 鹵0.92), (, 5.02 鹵0.99), (4.25 鹵0.61), (, 4.12 鹵0.54), respectively. The score of difficulty in defecation was (4.20 鹵0.77), (, 4.19 鹵0.81), the score of abdominal distending pain was (5.11 鹵0.68), (, 5.02 鹵0.76), the score of belching was (5.06 鹵0.79), (), the score of belching was (5.06 鹵0.79), (鹵0.75), and the score of abdominal distending pain was (5.11 鹵0.68), (, 5.02 鹵0.76). The scores of thoracic and hypochondriasis were (3.73 鹵0.61), (4.40 鹵0.64), (3.87 鹵0.66), (4.40 鹵0.64), (4.33 鹵0.51), respectively. The scores of each single item in the two groups were significantly different from those before treatment (P0.05), but there was no significant difference between the two groups (P0.05). The incidence of adverse drug reactions was 3.23% (2 / 62 cases) in the trial group and 4.92% (3 / 61 cases) in the control group (P0.05). Conclusion the clinical efficacy of Shaihuang Tongbian mixture and Muxiang betel nut pill in treating intestinal qi stagnation constipation is similar. Shaihuang Tongbian mixture is safe and effective in the treatment of intestinal qi stagnation constipation.
【作者單位】: 重慶醫(yī)科大學(xué)藥學(xué)院;南充市中心醫(yī)院藥劑科;南充市中心醫(yī)院中醫(yī)科;四川省南充衛(wèi)生學(xué)校醫(yī)學(xué)院;
【基金】:四川省科技廳應(yīng)用基礎(chǔ)計劃基金資助項目(2015JY0049) 四川省南充市科技局基金資助項目(N2008-SF016)
【分類號】:R256.35
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 李紅梅;鄭國榮;;淺談氣滯型便秘[J];中國民族民間醫(yī)藥;2011年23期
2 李林;張燕;任大成;別俊;李勝前;郭廷東;;芍黃通便合劑治療氣滯型便秘的臨床觀察[J];世界中西醫(yī)結(jié)合雜志;2012年12期
3 王和文;豐紀(jì)明;李培;;李培治療氣滯型便秘經(jīng)驗[J];四川中醫(yī);2010年02期
4 張燕;陳瑾歆;任大成;郭廷東;胡敏;韓平;;芍黃通便合劑治療腸道氣滯型便秘療效觀察[J];中華中醫(yī)藥學(xué)刊;2011年05期
5 余利華;;柴胡香檳湯治療氣滯型便秘36例[J];山東中醫(yī)藥大學(xué)學(xué)報;2013年01期
6 韓潔;王俊平;郭曉峰;郭麗君;;艽龍膠囊治療肝郁氣滯型便秘的臨床觀察[J];中國藥物與臨床;2012年04期
7 閆道普;于海榮;;加味五磨飲子治療老年氣滯型便秘56例[J];內(nèi)蒙古中醫(yī)藥;2009年24期
8 張建濤;莊保云;;推拿配合針刺療法治療氣滯型便秘的臨床觀察[J];中國衛(wèi)生標(biāo)準(zhǔn)管理;2013年Z3期
9 葉玲;任偉濤;鄭鳴霄;肖海濤;;承氣乙字湯治療腸道氣滯型便秘60例[J];福建中醫(yī)藥大學(xué)學(xué)報;2011年01期
10 柳冬兵;顧勤;;疏肝降氣治療腸道氣滯型便秘理論探討[J];遼寧中醫(yī)藥大學(xué)學(xué)報;2013年02期
相關(guān)重要報紙文章 前1條
1 本報記者 劉景峰;疏肝理氣施治結(jié)核所致便秘[N];醫(yī)藥經(jīng)濟(jì)報;2010年
相關(guān)碩士學(xué)位論文 前1條
1 楊愛龍;痔秘通3號治療肝郁氣滯型便秘的臨床觀察[D];黑龍江中醫(yī)藥大學(xué);2008年
,本文編號:2356184
本文鏈接:http://sikaile.net/zhongyixuelunwen/2356184.html